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ABSTRACT 
Objectives: The study was designed to build a financially stable, replicable, and interprofessional program around a Center of Excellence 
(COE) model exclusively in a community pharmacy setting. This involved creating a separate pharmacy-based clinic within the 
community pharmacy with recognized rendering providers by payers allowing pharmacists to bill incident to for services and increase 
the quality of patient clinical outcomes. Setting: Apple Discount drugs in Salisbury, MD is a multi-site independent community pharmacy 
setting offering traditional pharmacy services along with several pharmacist run clinical programs. Practice Innovation: The pharmacy 
developed an interprofessional team around a Center of Excellence (COE) model as a separate medical clinic within the community 
pharmacy as a subsidiary of the parent company that was staffed with healthcare providers that are recognized by payers to bill for 
services. Main Outcome Measures: Outcomes of the study included analysis of the number of patients seen, the ability to obtain 
reimbursement for the clinical services offered, and changes in A1C and BMI to support the clinical value of pharmacist intervention. 
Results:  A total of 309 patients with diabetes were seen over a 16 month period, including 120 patients who completed the 10 hour 
diabetes training program. Clinical outcomes showed an improvement in A1C from 9.1 pre enrollment to 7.5 post intervention, and a 
drop in BMI from 35.7 pre enrollment to 32.4 post intervention. The pharmacy was also able to increase the amount of reimbursement 
for services provided. Conclusions: The development of a pharmacy based clinic business model inside of a community pharmacy has 
increased the amount of clinically billed services for the pharmacy. Improvements in clinical outcomes led to an acceptance of the 
pharmacist as a member of the patient’s care team by patients, local physician’s offices, and third party payers.   
 
 
Background 
Pharmacists are amongst the most trusted healthcare 
professionals who are regularly approached by patients for 
expert advice1. Unfortunately, pharmacists are often 
overlooked as a member of the patient’s healthcare team. The 
value of clinical services that pharmacists can provide between 
primary care provider visits cannot be overstated. However, 
without methods to obtain reimbursement for clinical 
services, these services become a value added benefit that the 
pharmacy either gives away or are not allocated appropriate 
time for. Consequently, there is an absence in comprehensive 
patient therapy where pharmacists cannot innovatively 
expand upon and provide quality patient centered clinical 
continuation of care. A barrier to reimbursement is in part due 
to the inability of a pharmacist to be recognized with provider 
status and hence, this becomes a disadvantage because 
pharmacists are not reimbursed for clinical services that they 
routinely offer to their patients. Pharmacists are put in a 
position to search for unique solutions to reimbursement 
issues in order to keep clinical programs viable for their 
patients.  
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Diabetes affects 9.3% of all Americans and is the 7th leading 
cause of death in the United States2. A recent study supports 
that the involvement of pharmacists in the continuity of care 
of patients with type 2 diabetes is associated with significantly 
better glycemic control3. Pharmacy is currently limited to 
billing Medicare Part B for 10 hours of diabetes self-
management education and training (DSME/T) initially and 
only 2 hours each calendar year after the initial training takes 
place. This benefit does not recognize the pharmacist as a 
provider. The benefit is submitted under the durable medical 
equipment (DME) portion of the patient’s Medicare benefit4. 
Attributable to the lack of provider status, many commercial 
insurance companies will recognize DSME/T as a covered 
benefit for their patients; however, they will not recognize the 
pharmacist as a rendering provider to this service when the 
practice site is the community pharmacy. 
 
Diabetes education has been especially challenging in the tri-
county area of the lower Eastern Shore of Maryland5. Apple 
Discount Drugs, located in Salisbury Maryland, has endeavored 
to focus on expanding the role of the pharmacist outside of 
traditional dispensing. Due to the need for care of the 
geographical area surrounding the pharmacy and the desire of 
the pharmacy to provide these services, the pharmacy needed 
to develop a mechanism to increase revenue for its diabetes 
disease state education program. A pharmacy-based clinic 
model was created to put pharmacists in a position to help 
alleviate this gap in care by functioning as an extension to 
primary and specialty care.  
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OBJECTIVES 
The study was designed to build a financially stable, replicable, 
and interprofessional program around a Center of Excellence 
(COE)6 model exclusively in a community pharmacy setting. 
This involved creating a separate pharmacy-based medical 
clinic within the community pharmacy where pharmacists 
could have a mechanism to obtain reimbursement from third 
party payers to bill for services. The researchers also wanted 
to determine if the increase in quality patient centered clinical 
offerings would lead to an increase in patient loyalty to the 
retail areas of the community pharmacy.  
 
SETTING 
This study took place on the rural lower Eastern Shore of 
Maryland. The 2014 Census data estimates show that 16.7% of 
residents, in the pharmacy’s service area, live in poverty 
(Maryland overall average is 10.1%) and only 26% have a 
bachelor’s degree or higher. This leads to a lower standard of 
living with an average per capita income of $27,327, which is 
only 75% of the Maryland average4. Compounding the issues 
of low socioeconomic status, the Tri-County area on the lower 
eastern shore of Maryland rank first, second, and fourth in 
terms of unemployment rate in the state5. The rural nature of 
the tri-county area also makes access to providers more 
difficult for patients as the population density is one-quarter 
that of the Maryland average. To further exacerbate the need 
in this patient population the incidence of diabetes estimates 
at 12%7,8.  
 
Uninsured patients is at 15%9 with many more patients 
considered underinsured and lacking access to care. This 
means the number of actual patients with diabetes is likely 
much higher than estimates due to lack of access to needed 
care. The resources available for managing diabetes in this 
area are limited. There is only one other diabetes education 
center in the area, however, it does not perform any clinical 
interventions. Many individuals needing immediate care for 
complex diabetes issues are forced to travel to surrounding 
metropolitan areas for endocrinology services, a distance of 
120-150 miles. 
 
Practice Description 
Apple Discount Drugs is an independent, community pharmacy 
that serves the study area. Over the past several years, the 
pharmacy has explored increasing the clinical role of the 
pharmacist in serving the community outside of the traditional 
role of dispensing. The Apple Diabetes Center began offering 
individualized patient care services in 2009 and received 
American Association of Diabetes Educators (AADE) 
recognition as a DSME program in January 201110. Apple 
Discount Drugs began focusing on MTM in 2010 and has been 
recognized on both the state and national levels for the quality 
of clinical services provided to patients11,12. 
 
PRACTICE INNOVATION 
In order to increase the amount of clinical services that the 
pharmacy offered, the researchers created a separate 
pharmacy-based medical clinic as a subsidiary of the parent 
company that was staffed with healthcare providers that are 
recognized by payers to bill for services. The pharmacists, in 
collaboration with rendering providers for billable services, 
could increase the number of patients seen, the quality of the 
patient clinical outcomes, and the number of billable clinical 
services that the pharmacy offers.  
 
The interprofessional team that the clinic utilized consisted of 
clinical pharmacists, a dietician, a nurse practitioner, and a 
physician medical director. The retail business of the pharmacy 
was able to share some ancillary staff with the COE that 
included the billing specialist to submit claims to third party 
insurance and collect copayments.  
 
The researchers implemented this model by targeting an 
unmet need in diabetes care to increase reimbursement for 
DSME services since the pharmacy already had the 
infrastructure in place to provide this service, however, this is 
an initial step in creating a mechanism for reimbursement that 
will work across any disease state.  
 
Methods 
Legal Consultation for creation of the Center of Excellence 
Model 
In August 2014, the pharmacy administrators first retained a 
lawyer who specializes in medical and pharmacy legal issues to 
address any legal obligations for the community pharmacy and 
new clinic. The legal team looked at potential barriers and 
assessed the overall need to use this approach of building a 
separate entity, such as the center for excellence, as opposed 
to billing third party payers as a traditional pharmacy. 
However, there were no mechanisms for credentialing a 
pharmacist working out of a community pharmacy setting. It 
was also determined that the practitioners that could be 
credentialed for billing purposes, such as nurse practitioners 
or dieticians, could not assign benefits to the pharmacy-based 
diabetes center.  
 
The legal team identified that many of the potential 
commercial payers would recognize a pharmacy-based 
medical clinic if the clinic were licensed as a medical clinic as 
opposed to a pharmacy. Therefore, creating a center for 
excellence ‘clinic’ model operating under the community 
pharmacy business was the best approach for the expansion of 
clinical services. Once the decision was made, a new company 
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was incorporated into Apple Discount Drugs to house the 
clinic, the Apple Core Clinical Care. A new tax ID and NPI were 
obtained for the new business and determination of the 
staffing model began.  
 
The study was institutional review board (IRB) exempt. This 
study only changed the way the way the pharmacy presented 
itself for billing and marketing purposes. Informed consent to 
provide education and clinical services was obtained from the 
patient at the first encounter in the same manner that was 
traditionally used prior to this study. 
 
Interprofessional Team 
The interprofessional team recruited by the pharmacy clinic 
comprised of the clinical pharmacists, a dietician, a nurse 
practitioner, and a physician medical director. A billing 
specialist was also recruited to submit claims to third party 
insurance and collect copayments from patients. During the 
duration of the study, the State of Maryland introduced a law 
that allows a nurse practitioner the ability to practice 
independent of physician oversight. This opportunity allowed 
the pharmacy to reach out to nurse practitioners to function 
as rendering providers, creating an added benefit where the 
pharmacy could save money by hiring a nurse practitioner for 
less rather than a medical doctor.  
 
Given that the rendering provider may have had a relationship 
with outside provider offices that could potentially be referring 
patients into the clinic. To avoid possible Stark law violations 
and the possible perception that the clinic may be paying 
providers or rendering the provider something of value in 
exchange for referrals, it was agreed that hiring a rendering 
provider, regardless of the level of license, as an hourly 
employee rather than paying the provider a per diem per 
patient was the best way to avoid a potential Stark violation. 
An appropriate hourly figure was determined according to the 
average salaries for healthcare practitioners based on the level 
of licensure in the area. The salary was negotiated with the 
provider based on experience or other intangible qualities that 
the clinician brought to the clinic.  
 
Commercial Payers and Billing 
The pharmacy’s legal team was involved in credentialing and 
contacting commercial payers in order to credential clinical 
pharmacists with available payers. The rendering providers of 
medical services also made sure that they were credentialed 
with the same payer groups. The pharmacy’s liability insurance 
was notified of the new clinic and coverage was adjusted so 
that all licensed personnel had appropriate coverage.  
 
Third party payers contracted directly with the pharmacy clinic 
utilized a contract language that was typically similar to that 
used with traditional medical office clinic sites. Due to this, the 
legal team would typically ask for an addendum to be added 
to contracts to specify that the Center for Excellence 
pharmacy-based clinic was mainly focused on disease state 
education and not in the practice of medical diagnosis, 
prescribing, or dealing with controlled substances. 
 
Clinical Diabetes Program 
The clinic program was marketed through local media and 
referral sources. The patients who took part in the program 
were mainly referred by local prescribers, self-referred, and 
from other members of the pharmacy’s staff working with 
patients in traditional pharmacy services. The referring 
prescriber faxed results of study patients’ most recent lab 
work, history and physical, and medication reconciliation. If 
the patient had been self-referred, that clinic contacted the 
patient’s healthcare provider directly for patient medical 
records. The State of Maryland health information exchange, 
CRISP, authorized the pharmacy on-line access to health 
information8, allowing access to lab results and some baseline 
history for some of the patients managed by Apple Discount 
Drugs.  
 
A total of 309 patients were enrolled in the program with 11 
prediabetes patients, 6 Type 1 Diabetes Mellitus (T1DM) 
patients, and 284 type 2 Diabetes Mellitus (T2DM) patients. 
The group included 165 female and 144 male patients. The age 
group included 16 patients who were between 19 to 44 years, 
143 patients between 45 to 64 years and 150 patients who 
were greater than the age of 64 years.  
 
The formal diabetes education program was transferred from 
the traditional main community pharmacy to the Apple Core 
Clinical Care, the Center for Excellence clinic. The transfer kept 
the revenue generated from the clinical care program and the 
traditional services separated, making it easier to track the 
results of this study.  
 
In September 2014 the DSME/T program was initiated at the 
pharmacy and was based off of the AADE713 curriculum and 
core components of MTM; however, the program was 
structured and adjusted to meet the individual needs of the 
patient where a combination of group and individual 
counseling sessions were developed based on patient specific 
needs. For instance, special needs patients who were not 
deemed candidates for group participation were offered 
classes as one-on-one learning sessions with a CDE that was 
based on similar content as the group classes tailored to their 
required special needs.   
 
Initially, patients underwent a counseling session whereby a 
pharmacist CDE worked one-on-one with the patient. The 
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initial meeting with the patient enabled the pharmacist to gain 
an understanding and identify any knowledge deficit that the 
patient may have towards their current health status. It also 
allowed the pharmacist to set patient specific goals, and 
recommend medication and lifestyle interventions that 
catered to the individual when indicated. Patient education 
included detailed instruction in healthy eating, staying active, 
monitoring their disease, taking medications, problem solving, 
reducing risks, and developing healthy coping skills. These 
educational methods provided tools to set individualized, 
realistic, and obtainable goals with the intent of the patient 
taking ownership of their own care. Once classes were 
completed, patients scheduled follow-up appointments with 
the clinic to go over their progress toward meeting their 
treatment goals. The pharmacist then provided education, 
coaching, or made suggested medical interventions back to the 
patient’s prescriber. Many of the interventions that the 
pharmacist would suggest were based on managing side 
effects, pharmacoeconomics, adherence, and guideline based 
therapy omissions. A interprofessional healthcare team 
approach was encouraged through the clinic where clinicians, 
pharmacists, nurse practitioners, and dieticians worked 
collaboratively with patients to bring their expertise and 
alternative perspectives into the diabetes education 
experience.     
 
To document the number of patients that attended each class, 
the pharmacy developed a sign in sheet where patients logged 
their attendance to each group session.  The ability to prove 
attendance was important due to the fact that, unlike 
Medicare, some of our third party commercial payers paid at a 
different rate based on the size of the group class. 
 
Evaluation 
Data was collected using the AADE7 software system. This 
allowed the researchers to store encounter notes and run 
reports that compared clinical outcomes of patients. Economic 
outcomes were compiled using the CPR+ software system.  
 
RESULTS  
Clinical Implications  
A total of 309 patients with prediabetes patients, Type 1 
Diabetes Mellitus (T1DM) patients, and type 2 Diabetes 
Mellitus (T2DM) patients were seen between the months of 
September 2014 to December 2015, who had at least one visit 
within the clinic model. Of the patients enrolled, 120 patients 
graduated the DSME/T 10 hour training course. The average 
drop in A1C was from an A1C of 9.1 (pre-enrollment) to 7.5 (1.6 
average drop in A1C) in those patients that completed the 
entire course cycle and graduated the DSME/T class. Patients 
who completed the class cycle also experienced a drop in body 
mass index (BMI) from an average of 35.7 (pre-intervention) 
down to 32.4 (3.3 average drop in BMI) at 6 months-post 
graduation (Table 1).  
 
New Approaches – Billable Pharmacist Services 
The pharmacy successfully presented its outcome data and the 
interprofessional model of care to the commercial third party 
payers to support the effectiveness of the clinics pharmacy 
rendered services at providing direct patient care. As a result 
of the beginning successes of the study, the largest commercial 
payer in the pharmacy’s service area formed a pilot program 
that granted the pharmacist/CDEs a limited provider status to 
offer DSME/T. During the study, a positive reputation of the 
clinic was relayed by the patients enrolled in the study to their 
healthcare providers. The newly found respect of healthcare 
providers towards the benefits of the innovative services 
provided by the pharmacists in the study encouraged third 
party payers to become a large referral source to the program. 
With healthcare providers support and our persistent contact 
with third party payers, the patient centered medical home 
(PCMH), in association with third party payers, comprised a 
large referral source into the pharmacy and granted the clinical 
pharmacists access to view patients’ clinical portal that 
contained all documentation relevant to clinical care, including 
nursing notes, medication refill history, and laboratory results.    
 
Due to the clinical successes that pharmacists had with 
patients, one large third party insurer is attempting to remodel 
their patient portal to allow the pharmacist to leave clinical 
notes back to care coordinators. Having healthcare 
professionals on staff that are recognized by third party payers 
as providers increased the ability of the pharmacy to directly 
bill for more of the clinical services. Third party payers did not 
require any additional training or certifications such as a 
PharmD degree or MTM training, however, they did ask 
pharmacists providing the services to be a Certified Diabetes 
Educator (CDE)14. 
 
Economic Outcome 
The largest source of revenue and billable patient subset that 
the pharmacy serviced came as a result of gaining a direct 
provider status granted by a specific third party payer who 
enabled the pharmacy to directly bill for services the clinical 
pharmacist provided to the patient. Billing in this manner 
meant the pharmacy was able to collect payment and did not 
have split reimbursements with any other credentialed 
practitioners. With the help of the credentialed rendering 
providers within the clinic model, the pharmacy was able to 
increase the amount of ‘incident to’ billing opportunities. 
However, as the pharmacy clinic obtained direct limited 
provider status allowing for direct billing, the billing incident to 
rendering providers represented a reduced number of claims. 
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While the pharmacy did incur expenses for additional 
employees. This led to additional revenue coming into the 
pharmacy for a service that was traditionally limited to a 
smaller group of patients and given away free of charge. In the 
first year of the clinic model, the pharmacy was able to 
generate 2 times the amount of revenue when compared to 
previous year’s revenue where the pharmacy only billed for 
DSME/T as part of the Medicare Part B benefit through the 
DME department.   
 
Discussion 
With dwindling reimbursements to pharmacies for dispensing, 
it is imperative for community pharmacists to explore other 
avenues to allow a viable increase in revenue. In return, 
reimbursement for clinical services rendered by a pharmacist 
will support better utilization of pharmacist clinical skills in 
order to advance patient health as part of a interprofessional 
healthcare team. As the most accessible members of 
healthcare, pharmacists are well trained and in a prime 
position to offer patient care that is individualized to various 
chronic conditions. Although Medication Therapy 
Management (MTM) offers pharmacists some ability to 
provide services to patients, the lack of volume and 
reimbursement schedules are often not robust enough to 
sustain a clinical program.  
 
Prior to building the clinic model that focused on diabetes 
education and therapy management in a community 
pharmacy setting, the pharmacy could only bill DSME/T under 
the Medicare Part B benefit through the pharmacy DME 
department. While the pharmacy is still struggling to bill all 
commercial payers, the clinic model has helped the pharmacy 
to dramatically increase the number of billable intervention. 
This has been achieved by the use of incident to billing as well 
as, a dramatic increase in the number of payers who due to our 
study, now view our clinical pharmacists as providers. With the 
success of creating additional revenue sources, the pharmacy 
was able to dedicate more pharmacist hours to clinical services 
outside of the traditional roles of dispensing. In accordance 
with the success of this study, should national provider status 
for pharmacists pass, pharmacists can further expand this 
study model to include other chronic conditions. Future goals 
include that pharmacists gain the ability to directly bill for 
services without the need to bill incident to another provider. 
Direct billing should have a profound impact on a pharmacy’s 
ability to keep clinical programs viable.  
 
The billing complexities were carefully evaluated in 
determining the COE model. Members of the interprofessional 
team such as the dietician and nurse practitioner, were 
technically able to bill for services that they rendered before 
the clinic model was adapted. However, independent billing 
would have proved to be a challenging arrangement to this 
study because it meant the billing would have had to be done 
by the individual rendering provider and there was no entity 
for the provider to assign the monetary benefits. This meant 
that the provider would be paid as an independent contractor 
and would have to pay the pharmacy for the time and space to 
work with patients. In return, the rendering provider would 
also have to pay tax on the income obtained directly and then 
make deductions based on what was paid back into the 
pharmacy as well as provide their own billing. This would have 
been a highly unorganized and cumbersome billing process, 
the clinic model alleviated these issues where the claim was 
still billed under the rendering provider’s NPI number 
however, benefits were assigned back to the clinic. This 
allowed for billing to be completed by the pharmacy’s billing 
department and the rendering provider to be paid as an 
employee rather than a contractor.  
 
Due to the additional services that were offered by the 
pharmacy and clinic, a large portion of patients who were 
referred to the clinic but who had their prescriptions filled at 
other pharmacies would commonly have prescriptions 
transferred to the pharmacy, adding additional revenue. The 
ability of the pharmacy to integrate clinical services and 
medication management into a patient’s pharmacy care has 
been the decisive factor that has been cited by a large portion 
of patients in this subset to make this decision. It has been 
noted by the clinical staff that patients seem more engaged 
and have better medication adherence after interaction with a 
clinical pharmacist.  
 
The new traffic into the pharmacy also allowed the clinical 
pharmacist to increase the number of clinical offerings with 
the goal of reducing the incidence and progression of various 
chronic conditions. Patients are now routinely screened for co-
morbidities during DSME/T. Pharmacist screen patients for 
obstructive sleep apnea, diabetes depression/distress, 
hypertension, and the insurance that immunization status is 
up to date. There has also been an increase in the number of 
over the counter diabetes supplies sold by the retail pharmacy 
since the founding of the clinic.  
 
An unexpected barrier to service included patient’s 
unawareness of paying co-payments and deductibles in a 
pharmacy setting. Even though patients traditionally expect to 
pay for these services when they are rendered in a physician’s 
office or hospital setting, it was a new experience for many 
patients to pay a co-payment for pharmacist services. To 
overcome this barrier, the pharmacy clinic reached out to third 
party payers to attempt to bundle services such as the diabetes 
classes, into one service rather than having to bill multiple 
dates of services and billing the patient for multiple co-
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payments. So far there has been little acceptance of this 
proposal by commercial payers but the pharmacy has been 
allowed to present the concept to the decision makers at 
higher levels inside the third party payer. Most payers are still 
viewing the group classes much like a shared medical 
appointment15 that requires co-payment at each service visit 
rather than a series of classes making up a single product which 
would have a single co-payment.  
 
In order to insure patients are aware of any co-payments, the 
clinic created a form for invoicing educational services 
rendered in the pharmacy. The form contained the date and 
duration of time spent with the pharmacist, it also explained 
that the insurance would be billed for the services rendered, 
the process involved, and any remaining co-payments 
depending on the benefits of their insurance plan. An intake 
sheet for newly referred patients was also created that 
detailed necessary clinical data from prescribers and the billing 
department so that they can verify benefits prior to a patient 
coming in for services. Prior to a patient’s initial appointment 
to the clinic, the documents insured that an alert can be sent 
to the patients’ insurance plan’s benefit structure in terms of 
copayment and deductible prior to having services rendered.    
 
When the pharmacy initially began its clinical program, a 
perception that the pharmacist was competing with the 
physician for the care of a given patient presented some 
difficulties and interacting with local physicians proved to be a 
challenge. However, the program has helped the clinical 
pharmacists working out of the community pharmacy to gain 
the acceptance of local physician groups and provide 
awareness towards the benefits of a pharmacist getting 
involved in their patients’ healthcare. The local providers 
began to view pharmacists as an extension to primary care 
rather than competition and a central part to the continuity of 
patient therapy between doctor visits.  Our services also 
opened up patients to take more of a proactive role in their 
own care and this in return, made the physician’s job a lot 
easier because they were able to manage their patients’ 
diabetes more effectively. The positive outcomes seen by 
patients in the clinic have made many of the pharmacist 
interventions more likely to be accepted. 
 
Our clinical pharmacists have always believed in the benefits 
of the program, whether the program was considered to be 
part of the pharmacy or the Center for Excellence. Gaining the 
acceptance of the local prescribers and some third party 
payers has helped grow the program exponentially. The 
pharmacy has been very proactive in marketing the clinic to 
local service areas16. However, having a physician actively 
promote the program and the benefits directly to the patient 
have proven to be the most beneficial form of program 
promotion. Due to the outcomes data produced by the 
pharmacist led diabetes center, referring physicians also began 
referring patients not only for diabetes care but also for 
patients in need of preventative care. In essence, the clinical 
pharmacists have effectively broadened the clinics services by 
seeing numerous patients diagnosed with pre-diabetes and 
managing the multiple co-morbidities that can lead to 
development of diabetes. The clinical pharmacists, with the 
help of the billing department are actively determining if these 
additional services are billable opportunities to help maximize 
revenue. 
 
The Center for Excellence clinic for diabetes management has 
been successful in billing DSME/T to commercial payers that 
prior to this study, would not contract with a pharmacy. The 
clinic thus far has not billed services other than DSME/T but 
the model, as designed, can be replicated across any disease 
state where services of continuity of care can be provided. The 
clinic will continue to use the increased reimbursement to 
attempt an expansion in the number of clinical services offered 
to our patients. 
 
Limitations 
There are several limitations that may render this study 
difficult to replicate. The level of licensure that is required to 
provide credentialed clinical services may vary from state to 
state and across health plan payers. Additionally, some of the 
payers will allow for the practitioner who is providing oversight 
to solely extend their availability over the phone, while some 
payers require patients to physically be on site. The level of 
oversight over the program by the rendering provider required 
to successfully bill the pharmacist’s time incident to may also 
vary between insurance plans.  
 
CONCLUSION 
The development of a pharmacy based clinic business model 
inside of a community pharmacy has increased the amount of 
clinically billed service opportunities for the pharmacy both 
directly from incident-to billing, as well as, a potential to 
achieve provider status directly from payers. Increases in 
revenues have allowed pharmacists to dedicate more time to 
promote patient continuity of care and enforce to patients the 
importance of taking a more proactive approach to their 
healthcare. Expansion of the pharmacy’s clinical services led to 
an increased traffic in the pharmacy, additional prescriptions 
filled, and an increase in the sales of over the counter 
products.  
 
Patients reported beneficial interactions with their 
pharmacists in a community pharmacy setting. Even though 
there was an initial resistance to pharmacist rendered services, 
the unique healthcare setting was shown to be advantageous 
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in that unlike a hospital or physician’s office, the community 
pharmacy had a neutral and friendly environment where 
patients did not perceive it as a place that was predominantly 
for the sick. Hence, patients took comfort in accessing the 
service and felt the accessibility of healthcare professionals 
such as pharmacists and nurse practitioners, beneficial 
between doctor visits. The study’s outcomes have led to an 
acceptance of the pharmacist as a member of the patient’s 
care team by local physician’s office and third party payers. 
Patients were also able to access pharmacists’ expertise for a 
more effective medication therapy management in order to 
achieve quality health outcomes that was adjusted to patient 
lifestyle and tailored to their therapy needs. 
 
While this example was employed with a goal to increase 
revenue around diabetes education, it was an initial expansion 
within a community pharmacy with the desire to create a 
mechanism for future reimbursement of pharmacist based 
services as part of a interprofessional healthcare team that will 
work across any disease state. 
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Table 1 
  
Pre-DSME Post-DSME 
 
A1C BMI A1C BMI 
Average 9.1 (± 2.1) 35.7 (±7.5) 7.5 (± 1.2) 32.4  (± 7.3) 
High 15.8 54.2 10.5 49.7 
Low 5.8 19.3 5.5 18.1 
 
 
 
 
 
 
 
 
 
Discuss Options with Legal Counsel
Set up new Center for Excellence LLC for 
Pharmacy based Clinical Services
Credential Center for Excellence with 
third party insurance payers
Bring Licensed Healthcare Providers into 
the Center for Excellence to provide 
direct oversight/work with patients
Market Pharmacy based Clinical Services 
to the local Community and referral 
services
Develop processes within the Center for 
Excellence for intake and to verify 
insurance benefits
Develop infastructure with the 
pharmacy or Center for Excellence to 
bill for Clinical Services
 
This flow chart depicts 
the order of services as it 
relates to setting up the 
Center for Excellence 
Model Clinic at Core 
Clinical Care. 
Geographical location 
and volume will help to 
govern the amount of 
expense and potential 
revenue that this model 
may bring in for clinical 
services. 
Figure #1 
